12/4
05:12 pm
cmpx
Compass Therapeutics, Inc. (CMPX) Presents at Evercore 8th Annual Healthcare Conference Transcript [Seeking Alpha]
Low
Report
Compass Therapeutics, Inc. (CMPX) Presents at Evercore 8th Annual Healthcare Conference Transcript [Seeking Alpha]
12/3
09:11 am
cmpx
Compass Therapeutics (NASDAQ:CMPX) is now covered by analysts at Citizens Jmp. They set an "outperform" rating and a $10.00 price target on the stock.
Low
Report
Compass Therapeutics (NASDAQ:CMPX) is now covered by analysts at Citizens Jmp. They set an "outperform" rating and a $10.00 price target on the stock.
12/3
08:06 am
cmpx
Compass Therapeutics (NASDAQ:CMPX) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $10.00 price target on the stock.
Medium
Report
Compass Therapeutics (NASDAQ:CMPX) is now covered by analysts at Canaccord Genuity Group Inc.. They set a "buy" rating and a $10.00 price target on the stock.
12/3
07:19 am
cmpx
Compass Therapeutics (NASDAQ:CMPX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
Medium
Report
Compass Therapeutics (NASDAQ:CMPX) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
12/3
07:18 am
cmpx
Compass Therapeutics (NASDAQ:CMPX) was given a new $10.00 price target on by analysts at JMP Securities.
Medium
Report
Compass Therapeutics (NASDAQ:CMPX) was given a new $10.00 price target on by analysts at JMP Securities.
12/3
06:04 am
cmpx
Compass Therapeutics (NASDAQ:CMPX) is now covered by analysts at Citigroup Inc.. They set an "outperform" rating on the stock.
Low
Report
Compass Therapeutics (NASDAQ:CMPX) is now covered by analysts at Citigroup Inc.. They set an "outperform" rating on the stock.
12/1
03:28 am
cmpx
Compass Therapeutics (CMPX) Is Up 17.2% After Analyst Highlights Pipeline Progress and Anticipated Tovecimig Data – Has the Bull Case Changed? [Yahoo! Finance]
Medium
Report
Compass Therapeutics (CMPX) Is Up 17.2% After Analyst Highlights Pipeline Progress and Anticipated Tovecimig Data – Has the Bull Case Changed? [Yahoo! Finance]
12/1
01:22 am
cmpx
Strong Analyst Confidence in Compass Therapeutics (CMPX) Driven by CTX-10726 Advancement [Yahoo! Finance]
Medium
Report
Strong Analyst Confidence in Compass Therapeutics (CMPX) Driven by CTX-10726 Advancement [Yahoo! Finance]
11/30
11:38 pm
cmpx
A Look at Compass Therapeutics (CMPX) Valuation Following Strong CTX-10726 Preclinical Data and Management Update [Yahoo! Finance]
Medium
Report
A Look at Compass Therapeutics (CMPX) Valuation Following Strong CTX-10726 Preclinical Data and Management Update [Yahoo! Finance]
11/27
06:17 am
cmpx
Compass Therapeutics (NASDAQ:CMPX) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
Medium
Report
Compass Therapeutics (NASDAQ:CMPX) was upgraded by analysts at Leerink Partnrs to a "strong-buy" rating.
11/25
09:08 am
cmpx
Compass Therapeutics to Participate in Upcoming December Investor Events [Yahoo! Finance]
Medium
Report
Compass Therapeutics to Participate in Upcoming December Investor Events [Yahoo! Finance]
11/25
08:00 am
cmpx
Compass Therapeutics to Participate in Upcoming December Investor Events
Low
Report
Compass Therapeutics to Participate in Upcoming December Investor Events
11/18
06:38 am
cmpx
Compass Therapeutics Inc. (CMPX) is A Buy on Wall Street on Robust Pipeline Development [Yahoo! Finance]
Low
Report
Compass Therapeutics Inc. (CMPX) is A Buy on Wall Street on Robust Pipeline Development [Yahoo! Finance]
11/8
01:13 am
cmpx
Compass Therapeutics (NASDAQ:CMPX) was upgraded by analysts at
Wall Stre
Low
Report
Compass Therapeutics (NASDAQ:CMPX) was upgraded by analysts at
Wall Stre
11/5
08:49 am
cmpx
Compass Therapeutics (NASDAQ:CMPX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $30.00 price target on the stock.
Medium
Report
Compass Therapeutics (NASDAQ:CMPX) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $30.00 price target on the stock.
11/5
07:30 am
cmpx
Compass Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Low
Report
Compass Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
11/4
09:00 am
cmpx
Compass Therapeutics Presents Preclinical Data on CTX-10726, a Differentiated PD-1 x VEGF-A Bispecific Antibody, at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting
Low
Report
Compass Therapeutics Presents Preclinical Data on CTX-10726, a Differentiated PD-1 x VEGF-A Bispecific Antibody, at the 40th Society for Immunotherapy of Cancer (SITC) Annual Meeting
11/3
08:00 am
cmpx
Compass Therapeutics to Participate in Upcoming November Investor Events
Low
Report
Compass Therapeutics to Participate in Upcoming November Investor Events
10/30
11:45 pm
cmpx
Piper Sandler Remains Bullish on Compass Therapeutics (CMPX) [Yahoo! Finance]
Low
Report
Piper Sandler Remains Bullish on Compass Therapeutics (CMPX) [Yahoo! Finance]
10/6
08:08 am
cmpx
Compass Therapeutics (NASDAQ:CMPX) is now covered by analysts at Lifesci Capital. They set an "outperform" rating and a $10.00 price target on the stock.
Low
Report
Compass Therapeutics (NASDAQ:CMPX) is now covered by analysts at Lifesci Capital. They set an "outperform" rating and a $10.00 price target on the stock.
10/6
08:01 am
cmpx
Compass Therapeutics (NASDAQ:CMPX) was given a new $10.00 price target on by analysts at Compass Point.
Low
Report
Compass Therapeutics (NASDAQ:CMPX) was given a new $10.00 price target on by analysts at Compass Point.
9/11
03:55 am
cmpx
Guggenheim Sees Compass (CMPX) Potential Driven by Biliary Tract Cancer Pipeline [Yahoo! Finance]
Low
Report
Guggenheim Sees Compass (CMPX) Potential Driven by Biliary Tract Cancer Pipeline [Yahoo! Finance]